PharmaShots | Incisive News in 3 Shots

Subscribe Now

Gannex

Gannex Reports First Patient Dosing in P-II Clinical Trial of ASC42 for the Treatment of Primary Biliary Cholangitis

Gannex Reports First Patient Dosing in P-II Clinical Trial of ASC42 for the Treatment of Primary Biliary Cholangitis

April 11, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us